A modified IFN obtained by modifying IFN so as to prolong the blood duration of IFN and make it to act specifically on tumor or eye tissue having neovasa. Namely, an interferon-dextran complex obtained by mixing interferon with dextran having a chelating ligand in the presence of a metal ion.
